Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015))

Brooke A. Schlappe, Jennifer J. Mueller, Oliver Zivanovic, Ginger J. Gardner, Kara Long Roche, Yukio Sonoda, Dennis S. Chi, Roisin E. O'Cearbhaill

Research output: Contribution to journal › Comment/debate

Abstract

The authors regret that there was an error in one of the author names. The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Pages (from-to)225
Number of pages1
JournalGynecologic Oncology
Volume143
Issue number1
DOIs
StatePublished - Oct 1 2016
Externally publishedYes

Fingerprint

Names
Emotions
Carcinoma
Drug Therapy
corrigendum

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Erratum : Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015)). / Schlappe, Brooke A.; Mueller, Jennifer J.; Zivanovic, Oliver; Gardner, Ginger J.; Long Roche, Kara; Sonoda, Yukio; Chi, Dennis S.; O'Cearbhaill, Roisin E.

In: Gynecologic Oncology, Vol. 143, No. 1, 01.10.2016, p. 225.

Research output: Contribution to journal › Comment/debate

Schlappe, BA, Mueller, JJ, Zivanovic, O, Gardner, GJ, Long Roche, K, Sonoda, Y, Chi, DS & O'Cearbhaill, RE 2016, 'Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015))', Gynecologic Oncology, vol. 143, no. 1, pp. 225. https://doi.org/10.1016/j.ygyno.2016.07.097
Schlappe BA, Mueller JJ, Zivanovic O, Gardner GJ, Long Roche K, Sonoda Y et al. Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015)). Gynecologic Oncology. 2016 Oct 1;143(1):225. https://doi.org/10.1016/j.ygyno.2016.07.097
Schlappe, Brooke A. ; Mueller, Jennifer J. ; Zivanovic, Oliver ; Gardner, Ginger J. ; Long Roche, Kara ; Sonoda, Yukio ; Chi, Dennis S. ; O'Cearbhaill, Roisin E. / Erratum : Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015)). In: Gynecologic Oncology. 2016 ; Vol. 143, No. 1. pp. 225.
@article{d936bb29fad64a0096ef6f7ef4ba0b71,
title = "Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015))",
abstract = "The authors regret that there was an error in one of the author names. The authors would like to apologise for any inconvenience caused.",
author = "Schlappe, {Brooke A.} and Mueller, {Jennifer J.} and Oliver Zivanovic and Gardner, {Ginger J.} and {Long Roche}, Kara and Yukio Sonoda and Chi, {Dennis S.} and O'Cearbhaill, {Roisin E.}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.ygyno.2016.07.097",
language = "English (US)",
volume = "143",
pages = "225",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Erratum

T2 - Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015))

AU - Schlappe, Brooke A.

AU - Mueller, Jennifer J.

AU - Zivanovic, Oliver

AU - Gardner, Ginger J.

AU - Long Roche, Kara

AU - Sonoda, Yukio

AU - Chi, Dennis S.

AU - O'Cearbhaill, Roisin E.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - The authors regret that there was an error in one of the author names. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that there was an error in one of the author names. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=84990175413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990175413&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2016.07.097

DO - 10.1016/j.ygyno.2016.07.097

M3 - Comment/debate

C2 - 27496397

AN - SCOPUS:84990175413

VL - 143

SP - 225

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -

Access to Document